We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LT:NSELarsen & Toubro Limited Analysis

Data as of 2026-08-01 - not real-time

₹3,938.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Larsen & Toubro is trading just above its short‑term moving average while remaining under its longer‑term averages, placing the price in a neutral technical zone. The relative strength index sits in the middle of its range and the MACD histogram is positive, hinting at modest bullish momentum despite a recent dip in trading volume. Market sentiment is strongly positive, reflected by an extreme‑greed reading and a consensus buy rating from analysts, while price targets suggest notable upside potential.
Fundamentally, the company is delivering solid top‑line growth and maintains respectable gross and operating margins, yet profitability at the bottom line is modest. Valuation metrics such as price‑to‑earnings and price‑to‑book are elevated relative to peers, and the balance sheet shows high leverage with debt outpacing cash. The dividend yield is low but the payout ratio remains comfortable, supporting the continuation of payouts. Overall, the stock offers a blend of growth attributes tempered by valuation and balance‑sheet considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical stance with price near support and resistance
  • Decreasing volume suggesting limited short‑term buying pressure
  • Valuation appears stretched relative to industry peers

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent revenue growth and improving forward earnings outlook
  • Analyst price targets indicate meaningful upside
  • Strategic diversification into renewable and high‑tech segments

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong order pipeline and exposure to emerging clean‑energy markets
  • High leverage that may constrain cash generation and dividend growth
  • Sustainable dividend policy but modest yield

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin5.59%
P/E Ratio32.7
Debt/Equity97.64
P/B Ratio5.0
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI52.7
Support₹3,720.00
Resistance₹4,068.00
MA 20₹3,871.74
MA 50₹3,991.77
MA 200₹3,970.26
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Target Price₹4,512.36
Upside/Downside14.56%
GradeOvervalued
TypeBlend
Dividend Yield0.96%

Risk Assessment

Beta0.63
Volatility16.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.